Original Article
A Newly Recognized Fastidious Gram-Negative Pathogen as a Cause of Fever and Bacteremia
N Engl J Med 1990; 323:1587-1593December 6, 1990
- Abstract
- Abstract
Background.
We identified a motile, curved, gram-negative bacillus as the cause of persistent fever and bacteremia in two patients with symptomatic human immunodeficiency virus infection. The same organism was subsequently recovered from a bone marrow—transplant recipient with septicemia and from two immunocompetent persons with week-long febrile illnesses. All the patients recovered after antimicrobial therapy.
Methods and Results.
Primary cultures of blood processed by centrifugation after blood-cell lysis yielded adherent, white, iridescent, morphologically heterogeneous colonies in 5 to 15 days. Subcultures grew in four days on chocolate, charcoal—yeast extract, or blood agar. The organisms stained weakly with safranin and were not acid-fast. Fluorescent-antibody tests for legionella and francisella were negative. Biochemical reactivity was minimal and difficult to ascertain. Agar-dilution testing revealed in vitro susceptibility to most antimicrobial agents tested. The cellular fatty acid composition of the isolates was similar, resembling that of Rochalimaea quintana or brucella species, but not Helicobacter pylori or species of campylobacter or legionella. As resolved by gel electrophoresis, cell-membrane preparations of all isolates contained similar proteins, with patterns that differed from that of R. quintana. Patterns of digestion of DNA from all isolates by EcoRV restriction endonuclease were virtually identical and also differed from that of R. quintana. On immunodiffusion, serum from one convalescent patient produced a line of identity with sonicates of all five isolates.
Conclusions.
This pathogen may have been unidentified until now because of its slow growth, broad susceptibility to antimicrobial agents, and possible requirement of blood-cell lysis for recovery in culture. It should be sought as a cause of unexplained fever, especially in persons with defective cell-mediated immunity. (N Engl J Med 1990; 323:1587–93.)
Media in This Article
Figure 1
Gram Stain of a Clinical Isolate, Revealing Fine, Curved, Lightly Staining Gram-Negative Rods (×610).Figure 2
Sodium Dodecyl Sulfate–Polyacrylamide-Gel Electrophoresis of Preparations of Cell-Membrane Protein (Silver Stain).Article Activity
- Article
THE pathogenic potential of uncommon microorganisms may be recognized first in immunocompromised hosts, in whom they cause opportunistic infection. Subsequently, some such organisms may be found to cause illness in normal hosts as well. We describe a newly identified, highly fastidious microorganism that caused bacteremic illness in three immunocompromised hosts, and was then isolated as the cause of a similar illness in two normal hosts.
Case Reports
Two illustrative case reports are provided. Pertinent data regarding all patients are given in Table 1Table 1
Epidemiologic and Clinical Characteristics of the Patients at Presentation.*.Patient 1
A 31-year-old man infected with human immunodeficiency virus (HIV) was seen with a fever (temperature to 40.8°C), chills, sweats, and weight loss in November 1986. Fever persisted despite empirical therapy with erythromycin and then cephalexin. A chest radiograph revealed no active disease. Sputum examinations revealed no malignant cells or potential pathogens. Blood cultures were negative after a 48-hour incubation. Fever remitted during two weeks of empirical treatment with oral trimethoprim–sulfamethoxazole but recurred after its discontinuation.
Examination in January 1987 revealed fever (temperature, 38.3°C), marked cachexia, and weakness. He had pancytopenia, lymphopenia, and hypoxemia. Liver enzyme levels in serum were elevated. Bronchoscopy revealed no pathogens or histopathologic features. Empirical treatment with parenteral trimethoprim–sulfamethoxazole induced severe nausea and was soon stopped. Hepatomegaly was the sole abnormality detected by computed tomography of the head and abdomen. Liver biopsy disclosed normal architecture with interspersed granulomata. Aspiration and biopsy of bone marrow revealed dyserythropoiesis without megaloblastic or microcytic changes. No organisms were seen in or cultured from liver or marrow. The results of lumbar puncture and cardiac sonography were normal. Studies for antibodies to brucella, tularemia, and fungi were negative; cultures of urine and the bully coat for cytomegalovirus were also negative.
After 15 days of incubation, a culture of blood subjected to blood-cell lysis and then centrifugation (lysis—centrifugation) grew a curved gram-negative bacillus. Two cultures obtained six days after the first also grew the same organism after a long incubation. Parenteral erythromycin therapy was begun, and the fever declined slowly over a two-week period. Five weeks later, the fever recurred despite renewed treatment with oral erythromycin, but further blood cultures were negative. Norfloxacin was substituted, and fever remitted permanently during the four weeks of therapy. Further blood cultures were negative.
The patient died less than a year later of progressive HIV-related neurologic disease and disseminated Mycobacterium kansasii infection.
Patient 5
A 40-year-old woman presented in August 1989 with a four-day history of fever (temperature to 39.4°C), chills, sweating, nausea, vomiting, frontal headache, back pain, and weight loss. Examination disclosed fever (temperature, 38.8°C), liver tenderness to percussion, and lower-extremity petechiae. She had thrombocytopenia, granulocytosis, and mild lymphopenia, but hemoglobin levels and coagulation and serum-chemistry profiles were normal. Aspiration and examination of bone marrow demonstrated increased numbers of megakaryocytes. Cerebrospinal fluid was normal. Autoantibody screening was negative, and complement levels were normal. Serologic testing revealed high antibody titers to Epstein–Barr virus and cytomegalovirus, but negative reactions for HIV, brucella species, Francisella tularensis, Rickettsia rickettsii, and Ehrlichia canis (serum samples obtained during the acute phase of the disease and during convalescence were used to test for the last two microorganisms). Urine cultures were negative for bacteria and cytomegalovirus. Blood for culturing was drawn once on hospital days 1 and 2 and twice on day 4, when the patient was still febrile. A 10-day course of oral tetracycline was started on day 4. The fever subsided in 24 hours, and platelet counts soon returned to normal.
After incubation periods of 10 to 14 days, all lysis—centrifugation blood cultures yielded a curved gram-negative bacillus. All biphasic blood cultures had been negative when discarded after seven days. The patient has remained well on follow-up.
Methods
Isolation and Characterization
Blood was inoculated into 10-ml lysis—centrifugation tubes (Isolator, Dupont, Wilmington, Del.) for Patients 1, 2, and 3. Culture sets consisting of a biphasic medium (Septi-chek, Roche Diagnostics, Nutley, N.J.) and a lysis—centrifugation tube were used for Patients 4 and 5. Biphasic cultures were kept for seven days. Cultures derived by centrifugation after blood-cell lysis were plated on fresh medium, including chocolate agar (proteose peptone number 3 agar base) and sheep's-blood agar (Columbia blood agar base), and incubated at 35°C in 5 percent carbon dioxide for at least 14 days. Suspect colonies were subcultured on heart-infusion rabbit-blood agar.
Motility was determined by microscopical examination of saline wet-mount preparations. Catalase testing was done with 3 percent hydrogen peroxide. The oxidase test was performed with O-paraphenylene-diamine (Marion Scientific, Kansas City, Mo.). Further biochemical testing was attempted with both conventional1 and commercially available (Micro-Scan, Baxter-Travenol, Sacramento, Calif.; API Rapid-Strep, Analytab Products, Plainview, N.Y.) approaches. The Centers for Disease Control in Atlanta further evaluated isolates 1, 2, and 3.
Direct fluorescent antibody testing for Legionella pneumophila groups 1 through 6 and L. micdadei conjugate A (with use of a commercial kit, Wampole Laboratories, Cranbury, N.J.) and for F. tularensis (with use of a reagent provided by the Centers for Disease Control) was performed. Susceptibility testing was done with single concentrations of antimicrobial agents incorporated in chocolate agar (prepared from GC medium base).2 The following concentrations (in milligrams per liter) of antimicrobial agents were used: penicillin, 0.12; ampicillin, 2.0; aztreonam, 8.0; gentamicin, 4.0; tobramycin, 4.0; trimethoprim–sulfamethoxazole, 2.0 and 40, respectively; norfloxacin, 4.0; ciprofloxacin, 2.0; chloramphenicol, 8.0; erythromycin, 0.5; rifampin, 2.0; tetracycline, 4.0; and vancomycin, 4.0. Sensitivity to nalidixic acid and cephalothin was determined by disk diffusion with 30-μg disks.
Analyses of Whole-Cell Fatty Acids
Cultures of each isolate and of strains of Helicobacter pylori, formerly Campylobacter pylori 3 (strain 7878, American Type Culture Collection [ATCC], Rockville, Md.), and Rochalimaea quintana (ATCC strain RV358) were harvested after a seven-day incubation at 35°C in 5 percent carbon dioxide on plates containing heart-infusion 5 percent rabbit-blood agar. Fatty acid methyl esters were made and chromatographed according to the techniques developed by Miller and Berger.4 Fatty acid methyl ester profiles were identified by a computer-assisted comparison of the retention times of the specimens with that of a standard quantitative mixture of fatty acid methyl esters (Microbial-ID, Newark, Del.).
Preparation of Cell-Membrane Proteins
A modification of a technique for the isolation of outer-membrane proteins from Haemophilus influenzae was used.5 Bacteria grown after a one-week incubation on chocolate agar at 37°C in 5 percent carbon dioxide were suspended in HEPES buffer and sonicated at 70 W in 15-second bursts until the solution was clear. After centrifugation at 1700×g, the remaining supernatant was ultracentrifuged at 100,000×g. The resultant pellet was resuspended in HEPES buffer with 1 percent sodium lauroylsarcosine and, after a 30-minute incubation at room temperature, ultracentrifuged. The final gelatinous pellet of cell-membrane protein was resuspended in distilled water and stored at -70°C after colorimetric measurement of protein content (Bio-Rad, Richmond, Calif.).
Electrophoresis
Sodium dodecyl sulfate–polyacrylamide-gel electrophoresis was performed with a resolving gel with a gradient of 7.5 to 15 percent and a 4 percent stacking gel. Samples containing 2 to 3 μg of cell-membrane protein were run in each lane, with molecular-weight standards in adjacent lanes. Electrophoresis was performed at 15 mA per gel in a water-cooled chamber and was halted when the tracking dye reached the lower edge of the gel. The resolving gel was then fixed and stained with silver.6
Patterns of DNA Digestion by Restriction Endonuclease
The technique of van Ketel et al.7 was used for restriction-endonuclease digestion. Bacteria grown as for the preparation of cell-membrane protein were suspended, incubated with lysozyme for 30 minutes, and then lysed with 1 percent sodium dodecyl sulfate for 15 minutes before overnight digestion with pronase (Sigma, St. Louis). Nucleic acids were twice extracted with phenol—chloroform—isoamyl alcohol (25:24:1), precipitated overnight in ethanol at -20°C, and centrifuged. The washed pellet was resuspended and incubated with RNase (Sigma) for one hour. DNA purification was completed with an additional extraction with phenol—chloroform—isoamyl alcohol, followed by chloroform extraction and overnight precipitation in ethanol. A total of 4 μg of each DNA specimen was digested for two hours with 40 units of EcoRV (Bethesda Research Laboratories, Gaithersburg, Md.). Digests loaded onto a 0.7 percent agarose gel were electrophoresed overnight at 40 V, stained with ethidium bromide, and transilluminated with ultraviolet A for observation.
Immunodiffusion Studies
Serum samples obtained from Patients 2, 3, and 5 at least a month after the resolution of their febrile illnesses were stored at -20°C. No earlier serum samples were used. Aliquots were thawed and placed in the central wells of agarose immunodiffusion plates. The peripheral wells contained whole-cell sonicates of suspensions of isolates 1 through 5 and, as controls, supernatant from a broth culture of Staphylococcus aureus (ATCC strain 29213) or a whole-cell sonicate of a suspension of R. quintana. A control plate contained serum from a patient with S. aureus bacteremia in the center well and the same peripheral-well contents as in the first plate. The plates were incubated in a humidified container at 37°C for a week, then viewed by transmitted indirect lighting.
Results
Isolates were recovered by extended incubation of lysis—centrifugation blood cultures (Table 1). Where there were paired lysis—centrifugation and biphasic cultures, two or more lysis—centrifugation cultures were positive in each case, whereas no biphasic cultures yielded organisms during the seven days they were incubated.
Subcultures from primary culture plates grew in four days at 35 or 37°C in 5 to 10 percent carbon dioxide (but not at 30 or 42°C or in the absence of oxygen or carbon dioxide) on chocolate, charcoal—yeast extract, or blood agar. Rabbit blood supported growth better than sheep's blood. Growth was best on fresh chocolate agar and poor on medium more than three weeks old. Hemin disks (0.01 or 0.1 percent) enhanced growth on older mediums. Satellite growth occurred around micrococcus species and S. aureus but not Escherichia coli or Pseudomonas aeruginosa. Growth was absent on Thayer Martin or campylobacter blood agar, or on agar lacking heme compounds, including mediums for mycobacteria and MacConkey agar.
Adherent white iridescent colonies were morphologically heterogeneous. The colonies consisted of small, slightly curved gram-negative rods (Fig. 1Figure 1
Gram Stain of a Clinical Isolate, Revealing Fine, Curved, Lightly Staining Gram-Negative Rods (×610).) measuring 0.6 by 1.0 μm on electron microscopy. The morphologic features suggested a species of campylobacter. When mounted in saline, all isolates displayed twitching motility that was especially notable with short forms. Attempts to stain flagella were unsatisfactory because of the autoadherence of the colonies. Flagella were not seen on electron microscopy. Organisms stained poorly with safranin and were non—acid-fast. Fluorescent antibody tests for legionella species and F. tularensis were negative.Isolate 1 was weakly catalase-positive, but isolates 2 through 5 were catalase-negative; none of them were oxidase-positive. Inadequate growth made all attempts at further biochemical characterization equivocal; all other tests — response to triple sugar iron agar and other measures of carbohydrate fermentation or oxidation, nitrate reduction, salt tolerance, and hippurate hydrolysis — were negative. The CDC found that the organism was oxidase-positive according to Kovac's method,8 but otherwise confirmed our findings pertaining to motility and the lack of other discernible biochemical activities. No classification of the organisms could be made.
All isolates were susceptible in vitro to cephalothin, aztreonam, trimethoprim–sulfamethoxazole, chloramphenicol, erythromycin, aminoglycosides, fluoroquinolones, and rifampin. All were resistant to nalidixic acid. Isolate 1 was resistant to penicillin and ampicillin (because of the production of beta-lactamase), as well as to vancomycin. Isolate 2 was resistant to tetracycline.
The whole-cell fatty acid composition of each isolate was determined as an alternative approach to biochemical characterization. The proportions of fatty acids were similar for all isolates (octadecenoic acid, 48 to 58 percent; octadecanoic acid, 21 to 26 percent; and hexadecanoic acid, 16 to 23 percent), closely resembling those of R. quintana and somewhat like those of brucella species,9 but unlike those of H. pylori, campylobacter species,10 , 11 or legionella species12 (Table 2Table 2
Cellular Fatty Acid Composition of Isolates 1 through 5, Brucella, Rochalimaea, Helicobacter, Campylobacter, and Legionella.).For all isolates, preparations of cell-membrane protein resolved by sodium dodecyl sulfate–polyacrylamide-gel electrophoresis contained similar major bands between 31 and 42 kd and minor bands at 19 kd and between 45 and 150 kd — a pattern that differed from that of R. quintana (Fig. 2Figure 2
Sodium Dodecyl Sulfate–Polyacrylamide-Gel Electrophoresis of Preparations of Cell-Membrane Protein (Silver Stain).). Patterns of EcoRV-produced DNA cleavage of all isolates were virtually identical and differed from that of R. quintana (Fig. 3Figure 3
DNA-Fingerprint Study.).By immunodiffusion, serum samples obtained during convalescence from Patient 2, who had a prolonged febrile illness, produced a line of identity with all five isolates (shown in Fig. 4Figure 4
Immunodiffusion Study. with isolates 1 through 4) but did not react with R. quintana or S. aureus. Serum samples obtained during convalescence from Patients 3 and 5, who had febrile illnesses lasting a week or less, and serum from a patient with S. aureus bacteremia did not react with any of the isolates or control organisms. In addition, a human serum specimen reactive with E. canis (at a dilution of 1:1024 by indirect immunofluorescence) did not immunoprecipitate with isolates 1 and 2.Discussion
We have isolated a previously unrecognized pathogen that caused bacteremic disease in five patients, three with immunologic dysfunction and two without. The organism is a highly fastidious, slender, curved, gram-negative motile bacillus that forms heterogeneous colonies under microaerophilic conditions. It requires an extended incubation for primary isolation from lysis—centrifugation blood cultures. It was susceptible in vitro to most antimicrobial agents tested. Highly similar concentrations of total cellular fatty acid, profiles of cell-membrane protein, and DNA-cleavage patterns were demonstrated among the isolates, and the antigenic identity of the isolates was shown by immunoprecipitation with serum samples obtained during convalescence from one patient.
The isolation of this bacterium resulted from laboratory practices designed to enhance the detection of disseminated pathogens, such as mycobacteria13 14 15 and Histoplasma capsulatum, 16 by lengthening the routine maintenance of plates of lysis—centrifugation cultures to at least two weeks. Before 1989 at the Oklahoma Medical Center, a routine blood culture from an adult consisted of inoculation of the specimen into a pair of conventional broth bottles. Lysis—centrifugation cultures were available by request when indicated. This was the case for Patients 1 through 3. In 1989 the routine blood-culture system for adults was changed to include one lysis—centrifugation tube and one biphasic culture to maximize microbial recovery.17
This pathogen may have been previously unrecognized because of its fastidious nature. Its low frequency of isolation is underscored by the fact that 6096 lysis—centrifugation blood cultures were processed at the Oklahoma Medical Center in 1989. Recognition also may have been retarded by the widespread use of antimicrobial agents, since it is broadly susceptible to most common agents.
Although sharing characteristics with pathogens such as R. quintana, Brucella canis, and H. pylori, this organism is clearly different. R. quintana, the cause of trench fever and the only known species of rickettsia cultivable on artificial medium,18 had a fatty acid profile most similar to that of our isolates. The chief difference was a ratio of C16:0 to C18:0 of greater than 1.0 for R. quintana and less than 1.0 for the isolates from the patients. However, R. quintana grew faster than our isolates and had substantially different colonial and microscopic morphologic features, profile of cell-membrane protein, and DNA-cleavage pattern.
No epidemiologic or clinical clues have suggested the environmental origin of this pathogen or the mechanism by which infection occurred. None of the patients knew each other. Their illnesses were sporadic, and they came from diverse areas of Oklahoma. All but one used water from municipal water supplies, and the well water used by the fifth patient did not harbor the organism. Some had healthy domestic pets. None recalled exposure to ticks or wild animals — a key issue in the light of the high rates of rickettsial diseases (Rocky Mountain spotted fever and human ehrlichiosis) in Oklahoma19 and the similarity of this organism to R. quintana.
No portal of infection was evident. Patients had normal chest examinations and radiographs. None had meningeal signs; cerebrospinal fluid was normal in the two who underwent lumbar puncture. Only one had skin lesions — petechiae resulting from platelet consumption. One patient with hepatomegaly and abnormal liver function had granulomata within normal liver architecture, but no organisms were found by special staining or culture. Results of urinalyses were normal; urine cultures were negative.
Responses to therapy differed notably. Before their presentation at our hospital, both the HIV-infected patients had received courses of antimicrobial agents to which their isolates ultimately demonstrated susceptibility in vitro, yet they remained febrile and had persistent bacteremia. Treatment lasting at least a month appeared to be necessary to eradicate the fever, although the organisms could no longer be cultured after the institution of antimicrobial therapy at our hospital. Septicemia developed in the bone marrow—transplant recipient who had been treated with steroids despite long-term therapy with an antimicrobial agent to which her isolate also was susceptible in vitro. However, she had a very prompt response to therapy with other agents. The immunocompetent hosts, who had febrile illnesses lasting several days, also had prompt disappearance of their symptoms within days of starting antimicrobial therapy.
Although the immunodiffusion technique was useful in demonstrating the antigenic similarity of the isolates, it was able to detect an antibody response only in the patient with prolonged fever (and likely prolonged antigenic exposure). Countercurrent immunoelectrophoresis was attempted with whole-cell sonicates of the five isolates, as well as of a clinical isolate of R. quintana and the ATCC type strain (VR-358). All yielded lines of precipitation with serum samples obtained during convalescence from Patients 2, 3, and 5; however, indistinguishable lines of precipitation also developed with several randomly selected serum samples from patients with bacteremia due to other organisms. This suggests that one or more ubiquitous antigens may resemble or be shared by the clinical isolates. Preliminary immunoblot studies using cell-membrane proteins as antigens have suggested to us that some normal human serum specimens also contain antibodies reactive with antigens of this organism.
Since this paper's submission, we have seen a previously healthy 30-year-old man in whom fever developed after a tick bite. He was initially treated empirically with tetracycline, and his symptoms disappeared. A lysis—centrifugation culture of blood obtained after his fever recurred in association with headache, photophobia, confusion, myalgia, and arthralgia yielded the organism described above (9 colony-forming units per milliliter) after eight days of incubation. The results of computed tomography of the brain and an examination of the cerebrospinal fluid were normal. The patient became afebrile after one dose of ceftriaxone and a day of parenteral chloramphenicol, and he completed treatment with oral doxycycline. A case of aseptic meningitis and persistent bacteremic illness due to an organism morphologically and biochemically comparable to the one described in this paper has since been described in a 30-year-old man after exposure to ticks in Arkansas.20
In summary, we have identified a pathogen capable of causing febrile illness associated with persistent bacteremia in immunocompromised and immunocompetent hosts. Its recognition in the laboratory is based on optimal handling of lysis—centrifugation blood cultures. It differs from previously described pathogens, and its prevalence, habitat, and mechanism of pathogenesis remain undetermined. It should be sought in the setting of cryptogenic fever, especially in persons with defective cell-mediated immunity.
Presented in part at the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, September 18–20, 1989.
We are indebted to Karen Krisher, Oklahoma State Department of Health, for performing legionella and francisella fluorescent antibody studies; to Dr. Robert E. Weaver, Centers for Disease Control, for analysis of isolates; to Denise Pickett, Oklahoma Medical Center, for assistance in the gas-chromatography studies; and to Tom Griffin, Veterans Affairs Medical Center, for assistance with photographic documentation.
Source Information
From the Departments of Medicine (L.N.S., D.W.C.) and Pediatrics (D.F.W.), University of Oklahoma Health Sciences Center, College of Medicine; the Clinical Microbiology Laboratories, Oklahoma Medical Center (D.F.W., D.H.); and the Medical Service, Veterans Affairs Medical Center, (L.N.S.), all in Oklahoma City. Address reprint requests to Dr. Slater at the Infectious Diseases Section (111-C), 921 Northeast 13th St., Oklahoma City, of 73104.
- References
References
1
Weaver RE, Hollis DG, Bottone EJ. Gram-negative fermentative bacteria and Francisella tularensis. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:309–29.
2
Washington JA II. Susceptibility tests: agar dilution. In: Lennette EH, Balows A, Hausier WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:967–71.
3
Goodwin
CrossRef4
Miller L, Berger T. Bacterial identification by gas chromatography of whole cell fatty acids. (Hewlett—Packard application note 228–41.) Avondale, Pa.: Hewlett—Packard, 1985.
5
Murphy
CrossRef | Web of Science | Medline6
Giulian
CrossRef | Web of Science | Medline7
van Ketel
Web of Science | Medline8
Farmer JJ III, Hickman-Brenner FW, Kelly MT. Vibrio. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:282–301.
9
Dees
Web of Science | Medline10
Lambert
Web of Science | Medline11
Goodwin
Web of Science | Medline12
Moss
Web of Science | Medline13
Macher
Web of Science | Medline14
Pierce
Web of Science | Medline15
Hawkins
Web of Science | Medline16
Paya
Web of Science | Medline17
Washington
CrossRef18
Vinson
Web of Science | Medline19
Rocky Mountain spotted fever and human ehrlichiosis — United States, 1989 . MMWR 1990; 39:281–4.
Medline20
Lucey D, Dolan M, Garcia M, et al. Bacteremia with a Gram-negative rod reactive with antisera to the cat scratch bacillus. In: Abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21–24, 1990. Washington, D.C.: American Society for Microbiology, 1990:180. abstract.
- Citing Articles (67)
Citing Articles
1
Jean Stiles. (2011) Bartonellosis in cats: a role in uveitis?. Veterinary Ophthalmology 14, 9-14
CrossRef2
Diana B. McShane, Heidi H. Kong, Sarah A. Myers. 2011. Bartonella Infections: Bacillary Angiomatosis, Cat Scratch Disease and Bartonellosis. , 58.1-58.10.
CrossRef3
Cristiane C. Lamas, Maria Angelica Mares-Guia, Tatiana Rozental, Namir Moreira, Alexsandra R.M. Favacho, Jairo Barreira, Alexsandro Guterres, Márcio N. Bóia, Elba R.S. de Lemos. (2010) Bartonella spp. infection in HIV positive individuals, their pets and ectoparasites in Rio de Janeiro, Brazil: Serological and molecular study. Acta Tropica 115:1-2, 137-141
CrossRef4
Lynn Guptill. (2010) Bartonellosis. Veterinary Microbiology 140:3-4, 347-359
CrossRef5
Sunlian Feng, Rickie W. Kasten, Jonathan A. Werner, Emir Hodzic, Stephen W. Barthold, Bruno B. Chomel. (2009) Immunogenicity of Bartonella henselae P26 in cats. Veterinary Immunology and Immunopathology 132:2-4, 251-256
CrossRef6
Richard H. Roe, J. Michael Jumper, Arthur D. Fu, Robert N. Johnson, H. Richard McDonald, Emmett T. Cunningham. (2009) Ocular Bartonella Infections. International Ophthalmology Clinics 48:3, 93-105
CrossRef7
Renata Ferreira Magalhães, Luiza Helena Urso Pitassi, Bruno Grosselli Lania, Maria Lourdes Barjas-Castro, Paulo Eduardo Neves Ferreira Velho. (2009) Bartonellosis as Cause of Death After Red Blood Cell Unit Transfusion. Ultrastructural Pathology 33:4, 151-154
CrossRef8
Ciro Maguiña, Humberto Guerra, Palmira Ventosilla. (2009) Bartonellosis. Clinics in Dermatology 27:3, 271-280
CrossRef9
Rolando Ulloa-Gutierrez, Alejandra Soriano-Fallas, Kattia Camacho-Badilla, Adriano Arguedas. (2009) 48th ICAAC/46th IDSA Annual Meeting: a pediatric perspective. Expert Review of Vaccines 8:2, 143-147
CrossRef10
Jane E. Koehler. 2008. Bartonella Infections in HIV-infected Individuals. , 425-436.
CrossRef11
D. Raoult. (2007) From Cat Scratch Disease to Bartonella henselae Infection. Clinical Infectious Diseases 45:12, 1541-1542
CrossRef12
Eremeeva, Marina E., Gerns, Helen L., Lydy, Shari L., Goo, Jeanna S., Ryan, Edward T., Mathew, Smitha S., Ferraro, Mary Jane, Holden, Judith M., Nicholson, William L., Dasch, Gregory A., Koehler, Jane E., . (2007) Bacteremia, Fever, and Splenomegaly Caused by a Newly Recognized Bartonella Species. New England Journal of Medicine 356:23, 2381-2387
Full Text13
M. Yu. Kirillov, A. P. Markov, I. V. Lopyrev, V. N. Pankratova, S. A. Levitskii, V. N. Bashkirov, G. B. Smirnov, A. N. Kruglov, V. A. Osadchaya, G. P. Frolova, G. V. Barmina, O. A. Morozova, M. Y. Kosoy. (2007) Molecular genetic techniques for typing of Bartonella isolates. Molecular Genetics, Microbiology and Virology 22:1, 7-15
CrossRef14
Mardjan Arvand, Hannah Schubert, Juliane Viezens. (2006) Emergence of distinct genetic variants in the population of primary Bartonella henselae isolates. Microbes and Infection 8:5, 1315-1320
CrossRef15
Ahmad M Al-Majali. (2004) Seroprevalence of and risk factors for Bartonella henselae and Bartonella quintana infections among pet cats in Jordan. Preventive Veterinary Medicine 64:1, 63-71
CrossRef16
J. E. Koehler, M. A. Sanchez, S. Tye, C. S. Garrido-Rowland, F. M. Chen, T. Maurer, J. L. Cooper, J. G. Olson, A. L. Reingold, W. K. Hadley, R. R. Regnery, J. W. Tappero. (2003) Prevalence of Bartonella Infection among Human Immunodeficiency Virus--Infected Patients with Fever. Clinical Infectious Diseases 37:4, 559-566
CrossRef17
Maria Carla Liberto, Giovanni Matera, Angelo G Lamberti, Giorgio S Barreca, Angela Quirino, Alfredo Focà. (2003) In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diagnostic Microbiology and Infectious Disease 45:2, 107-115
CrossRef18
Hidenori KABEYA, Emiko TSUNODA, Soichi MARUYAMA, Takeshi MIKAMI. (2003) Immune Responses of Immunocompetent and Immunocompromised Mice Experimentally Infected with Bartonella henselae. Journal of Veterinary Medical Science 65:4, 479-484
CrossRef19
Hidenori Kabeya, Soichi Maruyama, Mitsuhiro Irei, Rena Takahashi, Masaya Yamashita, Takeshi Mikami. (2002) Genomic variations among Bartonella henselae isolates derived from naturally infected cats. Veterinary Microbiology 89:2-3, 211-221
CrossRef20
Lorenzo Ciceroni, Massimo Fabbi, Simonetta Ciarrocchi, Antonella Pinto, Alessandra Ciervo, Rickie W Kasten, Bruno B Chomel. (2002) Characterization of the first Bartonella henselae strain isolated from a cat in Italy. Comparative Immunology, Microbiology and Infectious Diseases 25:4, 217-228
CrossRef21
Pierre Houpikian, Didier Raoult. (2002) Diagnostic methods. Infectious Disease Clinics of North America 16:2, 377-392
CrossRef22
B Pappalardo. (2001) Immunopathology of Bartonella vinsonii (berkhoffii) in experimentally infected dogs. Veterinary Immunology and Immunopathology 83:3-4, 125-147
CrossRef23
James A. Comer, Christopher D. Paddock, James E. Childs. (2001) Urban Zoonoses Caused by Bartonella , Coxiella , Ehrlichia , and Rickettsia Species. Vector-Borne and Zoonotic Diseases 1:2, 91-118
CrossRef24
V. A. J. Kempf, M. Schaller, S. Behrendt, B. Volkmann, M. Aepfelbacher, I. Cakman, I. B. Autenrieth. (2000) Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cellular Microbiology 2:5, 431-441
CrossRef25
Emmett T Cunningham, Jane E Koehler. (2000) Ocular bartonellosis. American Journal of Ophthalmology 130:3, 340-349
CrossRef26
O. Lortholary, J. -L. Mainardi, B. La Scola, V. Gallais, P. Frenaux, P. Casassus. (2000) Consecutive bacillary angiomatosis and Rhodococcus equi bacteremia during acute leukemia: zoonoses may cause fever in neutropenic patients. Clinical Microbiology and Infection 6:6, 334-336
CrossRef27
Raoult, Didier, Birg, Marie L.Scola, Bernard La, Fournier, Pierre E., Enea, MaryseLepidi, Hubert, Roux, Veronique, Piette, Jean-Charles, Vandenesch, François, Vital-Durand, Denis, Marrie, Tom J., . (2000) Cultivation of the Bacillus of Whipple's Disease. New England Journal of Medicine 342:9, 620-625
Full Text28
Ciro Maguiña, Eduardo Gotuzzo. (2000) BARTONELLOSIS. Infectious Disease Clinics of North America 14:1, 1-22
CrossRef29
L Guptill. (1999) Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae. Veterinary Immunology and Immunopathology 71:3-4, 233-243
CrossRef30
Christoph Dehio. (1999) Interactions of Bartonella henselae with vascular endothelial cells. Current Opinion in Microbiology 2:1, 78-82
CrossRef31
Tracy I. George, Geoffrey Manley, Jane E. Koehler, Virginia S. Hung, Michael McDermott, Andrew Bollen. (1998) Detection of Bartonella henselae by polymerase chain reaction in brain tissue of an immunocompromised patient with multiple enhancing lesions. Journal of Neurosurgery 89:4, 640-644
CrossRef32
Andrew W.O Burgess, Burt E Anderson. (1998) Outer membrane proteins ofBartonella henselaeand their interaction with human endothelial cells. Microbial Pathogenesis 25:3, 157-164
CrossRef33
David H. Spach, Jane E. Koehler. (1998) BARTONELLA-ASSOCIATED INFECTIONS. Infectious Disease Clinics of North America 12:1, 137-155
CrossRef34
J.Brian Reed, David K Scales, Michael T Wong, Charles P Lattuada, Matthew J Dolan, Ivan R Schwab. (1998) Bartonella henselae neuroretinitis in cat scratch disease. Ophthalmology 105:3, 459-466
CrossRef35
J.E. Foley, B. Chomel, Y. Kikuchi, K. Yamamoto, N.C. Pedersen. (1998) Seroprevalence of Bartonella henselae in cattery cats: Association with cattery hygiene and flea infestation. Veterinary Quarterly 20:1, 1-5
CrossRef36
Koehler, Jane E., Sanchez, Melissa A., Garrido, Claudia S., Whitfeld, Margot J., Chen, Frederick M., Berger, Timothy G., Rodriguez-Barradas, Maria C., LeBoit, Philip E., Tappero, Jordan W., . (1997) Molecular Epidemiology of Bartonella Infections in Patients with Bacillary Angiomatosis–Peliosis. New England Journal of Medicine 337:26, 1876-1883
Full Text37
Michael F Minnick, Kent D Barbian. (1997) Identification of Bartonella using PCR; genus- and species-specific primer sets. Journal of Microbiological Methods 31:1-2, 51-57
CrossRef38
M. Maurin, R. Birtles, D. Raoult. (1997) Current knowledge ofBartonella species. European Journal of Clinical Microbiology & Infectious Diseases 16:7, 487-506
CrossRef39
Akos Kovacs, Howard L. Leaf, Michael S. Simberkoff. (1997) BACTERIAL INFECTIONS. Medical Clinics of North America 81:2, 319-343
CrossRef40
MICHAEL W. DUNN, FRANK E. BERKOWITZ, JUDSON J. MILLER, JOSEPH A. SNITZER. (1997) Hepatosplenic cat-scratch disease and abdominal pain. The Pediatric Infectious Disease Journal 16:3, 269-272
CrossRef41
JAMES W. BASS, JUDY M. VINCENT, DONALD A. PERSON. (1997) The expanding spectrum of Bartonella infections: II. Cat-scratch disease. The Pediatric Infectious Disease Journal 16:2, 163-179
CrossRef42
Cabot, Richard C.Scully, Robert E., Mark, Eugene J., McNeely, William F., Ebeling, Sally H., Jacoby, George A.Hay, C. Mhorag. (1997) Case 2-1997. New England Journal of Medicine 336:3, 205-210
Full Text43
JAMES W. BASS, JUDY M. VINCENT, DONALD A. PERSON. (1997) The expanding spectrum of Bartonella infections: I. Bartonellosis and trench fever. The Pediatric Infectious Disease Journal 16:1, 2-10
CrossRef44
Rachel C. Abbott, Bruno B. Chomel, Rickie W. Kasten, Kim A. Floyd-Hawkins, Yoko Kikuchi, Jane E. Koehler, Niels C. Pedersen. (1997) Experimental and natural infection with Bartonella henselae in domestic cats. Comparative Immunology, Microbiology and Infectious Diseases 20:1, 41-51
CrossRef45
Robert C. Jerris, Russell L. Regnery. (1996) WILL THE REAL AGENT OF CAT-SCRATCH DISEASE PLEASE STAND UP? 1. Annual Review of Microbiology 50:1, 707-725
CrossRef46
H. -U. Schmidt, T. Kaliebe, J. Poppinger, C. Bühler, A. Sander. (1996) Isolation ofBartonella quintana from an HIV-positive patient with bacillary angiomatosis. European Journal of Clinical Microbiology & Infectious Diseases 15:9, 736-741
CrossRef47
Jean-Michel Lacroix, Keith Jarvi, Sukhsatej D. Batra, Dianne M. Heritz, Marc W. Mittelman. (1996) PCR-based technique for the detection of bacteria in semen and urine. Journal of Microbiological Methods 26:1-2, 61-71
CrossRef48
P Brouqui, D Raoult. (1996) Bartonella quintana invades and multiplies within endothelial cells in vitro and in vivo and forms intracellular blebs. Research in Microbiology 147:9, 719-731
CrossRef49
John I. Antonius, Salim M. Farid, Atilio Baez-Giangreco. (1996) Steroid-Responsive Rosai-Dorfman Disease. Pediatric Hematology-Oncology 13:6, 563-570
CrossRef50
Jane E. Koehler, Laurie Cederberg. (1995) Intra-abdominal mass associated with gastrointestinal hemorrhage: A new manifestation of bacillary angiomatosis. Gastroenterology 109:6, 2011-2014
CrossRef51
Spach, David H., Kanter, Andrew S., Dougherty, Molly J., Larson, Ann M., Coyle, Marie B., Brenner, Don J., Swaminathan, Bala, Matar, Ghassan M., Welch, David F., Root, Richard K., Stamm, Walter E., . (1995) Bartonella (Rochalimaea) quintana Bacteremia in Inner-City Patients with Chronic Alcoholism. New England Journal of Medicine 332:7, 424-428
Full Text52
Relman, David A., . (1995) Has Trench Fever Returned?. New England Journal of Medicine 332:7, 463-464
Full Text53
Gareth P. Jevon, W. Michael Dunne, Milton J. Finegold. (1995) An Analysis of Lymph Node DNA for Possible Bacterial Agents of Cat-Scratch Disease. Fetal & Pediatric Pathology 15:1, 3-9
CrossRef54
M.G. Davies. (1995) Coccal nail fold angiomatosis. British Journal of Dermatology 132:1, 162-163
CrossRef55
S. C. A. CHEN, G. L. GILBERT. (1994) Cat scratch disease: Past and present. Journal of Paediatrics and Child Health 30:6, 467-469
CrossRef56
Gary S. Cohen, David S. Ball, Robin Boyd-Kranis, Rosaleen B. Gembala, John Wurzel. (1994) Peliosis Hepatis Mimicking Hepatic Abscess: Fatal Outcome Following Percutaneous Drainage
. Journal of Vascular and Interventional Radiology 5:4, 643-645
CrossRef57
Adal, Karim A.Cockerell, Clay J.Petri, William A. Jr.. (1994) Cat Scratch Disease, Bacillary Angiomatosis, and Other Infections Due to Rochalimaea. New England Journal of Medicine 330:21, 1509-1515
Full Text58
T.L. Hadfield, R. Warren, M. Kass, E. Brun, C. Levy. (1993) Endocarditis caused by Rochalimaea henselae. Human Pathology 24:10, 1140-1141
CrossRef59
Koehler, Jane E., Quinn, Frederick D., Berger, Timothy G., LeBoit, Philip E., Tappero, Jordan W., . (1992) Isolation of Rochalimaea Species from Cutaneous and Osseous Lesions of Bacillary Angiomatosis. New England Journal of Medicine 327:23, 1625-1631
Full Text60
Desforges, Jane F., , Tompkins, Lucy S., . (1992) The Use of Molecular Methods in Infectious Diseases. New England Journal of Medicine 327:18, 1290-1297
Full Text61
David A. Relman, Paul W. Lepp, Kay N. Sadler, Thomas M. Schmidt. (1992) Phylogenetic relationships among the agent of bacillary angiomatosis, Bartonella bacilliformis, and other alpha-proteobacteria. Molecular Microbiology 6:13, 1801-1807
CrossRef62
DAVID H. SPACH. (1992) BACILLARY ANGIOMATOSIS. International Journal of Dermatology 31:1, 19-24
CrossRef63
(1991) The Causative Agent of Bacillary Angiomatosis. New England Journal of Medicine 325:20, 1447-1448
Full Text64
J. Holton, P. Nye, R. Miller. (1991) Mycobacterium haemophilum infection in a patient with AIDS. Journal of Infection 23:3, 303-306
CrossRef65
(1991) The Organism Causing Bacillary Angiomatosis, Peliosis Hepatis, and Fever and Bacteremia in Immunocompromised Patients. New England Journal of Medicine 324:21, 1514-1514
Full Text66
Eisenstein, Barry I., . (1990) New Opportunistic Infections — More Opportunities. New England Journal of Medicine 323:23, 1625-1627
Full Text67
(1990) Rickettsia-like opportunistic agent. The Lancet 336:8729, 1501
CrossRef
